What is the recommended dose of syrup furazolidone (Furazolidone) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Furazolidone Syrup for Pediatric Patients

The recommended dose of furazolidone syrup for pediatric patients is 7.5 mg/kg/day divided into 3-4 doses for 5-7 days, with treatment duration depending on the specific infection being treated.

Dosage Guidelines by Indication

Acute Infectious Diarrhea

  • Dosage: 7.5 mg/kg/day divided into 3-4 doses
  • Duration: 5 days
  • Evidence: Multiple clinical trials have demonstrated efficacy at this dosage for acute diarrheal illness 1, 2
  • Clinical outcome: This dosage has shown 87.8% clinical cure rate by day 3 in children with acute invasive diarrhea 1

Giardiasis

  • Dosage: 7.5 mg/kg/day divided into 3-4 doses
  • Duration: 10 days (important note: 5-day regimen showed only 20% cure rate)
  • Evidence: Research shows that 10-day treatment achieves 92% cure rate versus only 20% with 5-day treatment 3
  • Warning: Treatment duration less than 7-10 days is not recommended for giardiasis as it leads to high relapse rates

Typhoid Fever

  • Dosage: 7.5 mg/kg/day divided into 3-4 doses
  • Duration: 7-10 days
  • Evidence: This dosage has shown 86.2% clinical and bacteriologic cure in children with typhoid fever 4

Cholera

  • Dosage: 7.5 mg/kg/day divided into 3-4 doses
  • Duration: 7 days
  • Evidence: Has been shown to be as effective as tetracycline in reducing volume and duration of diarrhea in children with cholera 5

Administration Guidelines

  • Administer with food to minimize gastrointestinal side effects
  • Complete the full course of treatment even if symptoms improve before completion
  • Ensure adequate hydration during treatment, especially for diarrheal illnesses
  • Oral rehydration therapy should be used concurrently for diarrheal diseases

Important Precautions

  • Age considerations: Use with caution in neonates due to potential for hemolytic anemia
  • Monitoring: Watch for signs of nausea, vomiting, or allergic reactions
  • Drug interactions: Avoid concurrent use with alcohol or MAO inhibitors
  • Common side effects: Yellow discoloration of urine, nausea, vomiting, abdominal pain
  • Contraindications: G6PD deficiency, infants under 1 month of age

Clinical Pearls

  • Furazolidone is particularly valuable for treating infections caused by organisms resistant to other antibiotics
  • When treating giardiasis, the 10-day regimen is strongly recommended as shorter courses have high failure rates
  • For diarrheal illnesses, clinical improvement is typically seen within 48-72 hours of initiating treatment
  • In cases where furazolidone is ineffective after 3 days, consider alternative diagnoses or resistant organisms

This medication has demonstrated efficacy across multiple pediatric infectious conditions at the 7.5 mg/kg/day dosage, with treatment duration being the key variable depending on the specific infection being treated.

References

Research

Five v ten days' therapy with furazolidone for giardiasis.

American journal of diseases of children (1960), 1983

Research

Randomized clinical trial of furazolidone for typhoid fever in children.

Scandinavian journal of gastroenterology, 1993

Research

Furazolidone in paediatric cholera.

Bulletin of the World Health Organization, 1970

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.